Active Ingredient(s): Sermorelin, GHRH
FDA Approved: * December 28, 1990
Pharm Company: * SERONO
Category: Growth Hormone Treatment

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Geref Overview

Sermorelin acetate (INN; brand names Geref, Gerel), also known as GHRH (1-29), is a peptide analogue of growth hormone-releasing hormone (GHRH) which is used as a diagnostic agent to assess growth hormone (GH) secretion for the purpose of diagnosing growth hormone deficiency. It is a 29-amino acid polypeptide representing the 1–29 fragment from endogenous human GHRH, thought to be the shortest fully functional fragment of GHRH.[1][2] See also List of g...

Read more Geref Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Geref Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sermorelin, GHRH
  • Injection: 0.05mg/amp, 0.5mg, 0.5mg/vial, 1mg, 1mg/vial, 50mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Sermorelin, GHRH or a similar ingredient: (1 result)

Related Geref Topics:

Geref 200 , IV XI...